The impact of the active management of risk in pregnancy at term on birth outcomes: a randomized clinical trial.

PubWeight™: 3.16‹?› | Rank: Top 1%

🔗 View Article (PMC 2855849)

Published in Am J Obstet Gynecol on May 01, 2008

Authors

James M Nicholson1, Samuel Parry, Aaron B Caughey, Sarah Rosen, Allison Keen, George A Macones

Author Affiliations

1: Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA, USA.

Articles citing this

Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol (2010) 5.00

Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis. CMAJ (2014) 3.69

Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev (2012) 1.85

The association between increased use of labor induction and reduced rate of cesarean delivery. J Womens Health (Larchmt) (2009) 1.53

Risk factors for antepartum stillbirth and the influence of maternal age in New South Wales Australia: a population based study. BMC Pregnancy Childbirth (2013) 0.86

Timing of delivery and pregnancy outcomes among laboring nulliparous women. Am J Obstet Gynecol (2011) 0.82

The role of sepsis in the AMOR-IPAT Trial. Am J Obstet Gynecol (2008) 0.75

APPEARANCE OF NEURODEVELOPMENTAL DISORDERS IN CHILDREN DELIVERED POST-TERM: A CROSS-SECTION STUDY. Mater Sociomed (2016) 0.75

The active management of impending cephalopelvic disproportion in nulliparous women at term: a case series. J Pregnancy (2010) 0.75

"Preventive induction" fails to demonstrate benefits for mothers or newborn infants. Am J Obstet Gynecol (2008) 0.75

Active management of risk in pregnancy at term did not reduce caesarean delivery rates. Evid Based Med (2009) 0.75

Increased planned delivery contributes to declining rates of pregnancy hypertension in Australia: a population-based record linkage study. BMJ Open (2015) 0.75

Active management of risk in nulliparous pregnancy at term: association between a higher preventive labor induction rate and improved birth outcomes. Am J Obstet Gynecol (2009) 0.75

Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, randomised controlled trial. BMC Pregnancy Childbirth (2012) 0.75

Articles cited by this

Births: final data for 2005. Natl Vital Stat Rep (2007) 5.91

Elective induction of labour. A randomised prospective trial. Lancet (1975) 5.18

Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ (2007) 4.92

Infant mortality in the United States: trends, differentials, and projections, 1950 through 2010. Am J Public Health (1995) 4.70

Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med (1992) 4.11

Caesarean section and risk of unexplained stillbirth in subsequent pregnancy. Lancet (2003) 4.10

Elective primary cesarean delivery. N Engl J Med (2003) 3.91

Infant and neonatal mortality for primary cesarean and vaginal births to women with "no indicated risk," United States, 1998-2001 birth cohorts. Birth (2006) 3.80

Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ (2007) 3.46

Effects of teamwork training on adverse outcomes and process of care in labor and delivery: a randomized controlled trial. Obstet Gynecol (2007) 2.59

Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol (2006) 2.45

Relationship between malpractice claims and cesarean delivery. JAMA (1993) 2.32

Postpartum maternal mortality and cesarean delivery. Obstet Gynecol (2006) 2.25

Association between rising professional liability insurance premiums and primary cesarean delivery rates. Obstet Gynecol (2007) 2.13

Active management of risk in pregnancy at term in an urban population: an association between a higher induction of labor rate and a lower cesarean delivery rate. Am J Obstet Gynecol (2004) 2.08

Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis. Obstet Gynecol (2003) 2.05

Induction of labor and the relationship to cesarean delivery: A review of 7001 consecutive inductions. Am J Obstet Gynecol (1999) 2.02

Prevalence and persistence of health problems after childbirth: associations with parity and method of birth. Birth (2002) 1.95

Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term: the international randomized Term Breech Trial. Am J Obstet Gynecol (2004) 1.83

The impact of the interaction between increasing gestational age and obstetrical risk on birth outcomes: evidence of a varying optimal time of delivery. J Perinatol (2006) 1.77

Complications of cesarean deliveries: rates and risk factors. Am J Obstet Gynecol (2004) 1.72

Induction of labor versus expectant management in macrosomia: a randomized study. Obstet Gynecol (1997) 1.68

The epidemiology of labor induction: Arizona, 1997. Am J Obstet Gynecol (2000) 1.64

Induction of labor and cesarean delivery by gestational age. Am J Obstet Gynecol (2006) 1.62

Cesarean delivery and the risk-benefit calculus. N Engl J Med (2007) 1.61

Risk of cesarean delivery with elective induction of labor at term in nulliparous women. Obstet Gynecol (1999) 1.61

Management of prolonged pregnancy: induction of labor versus antepartum fetal testing. Am J Obstet Gynecol (1987) 1.56

Complications of term pregnancies beyond 37 weeks of gestation. Obstet Gynecol (2004) 1.54

Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev (2004) 1.53

Outcome after elective labor induction in nulliparous women: a matched cohort study. Am J Obstet Gynecol (2002) 1.40

Risks of adverse outcomes in the next birth after a first cesarean delivery. Obstet Gynecol (2007) 1.38

Neonatal complications of term pregnancy: rates by gestational age increase in a continuous, not threshold, fashion. Am J Obstet Gynecol (2005) 1.35

Maternal and obstetric complications of pregnancy are associated with increasing gestational age at term. Am J Obstet Gynecol (2007) 1.35

A preventive approach to obstetric care in a rural hospital: association between higher rates of preventive labor induction and lower rates of cesarean delivery. Ann Fam Med (2007) 1.30

Outcomes of pregnancy beyond 37 weeks of gestation. Obstet Gynecol (2006) 1.13

Pelvic floor trauma following vaginal delivery. Curr Opin Obstet Gynecol (2006) 1.12

Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol (1993) 1.11

Modified Bishop's score and induction of labor in patients with a previous cesarean delivery. Am J Obstet Gynecol (2004) 1.04

Prolonged pregnancy: induction of labor and cesarean births. Obstet Gynecol (2001) 1.03

Development of a large-scale obstetric quality-improvement program that focused on the nulliparous patient at term. Am J Obstet Gynecol (2004) 1.02

Indicated labor induction with vaginal prostaglandin E2 increases the risk of cesarean section even in multiparous women with no previous cesarean section. J Perinat Med (2004) 1.01

Secular trends in cesarean delivery rates among macrosomic deliveries in the United States, 1989 to 2002. J Perinatol (2005) 1.00

Comparison of elective induction of labor with favorable Bishop scores versus expectant management: a randomized clinical trial. J Matern Fetal Neonatal Med (2005) 0.98

A randomized controlled trial of selective planned delivery. Br J Obstet Gynaecol (1978) 0.97

Prevention of urinary and anal incontinence: role of elective cesarean delivery. Curr Opin Obstet Gynecol (2003) 0.92

Elective induction of labor: should we make a fuss? Am J Obstet Gynecol (2004) 0.89

Oligohydramnios in uncomplicated pregnancies beyond 40 completed weeks. A prospective, randomised, pilot study on maternal and neonatal outcomes. Fetal Diagn Ther (2005) 0.87

Elective induction of labor at 39 weeks of gestation: a prospective randomized trial. J Obstet Gynaecol Res (1999) 0.87

WITHDRAWN: Interventions for preventing or improving the outcome of delivery at or beyond term. Cochrane Database Syst Rev (2007) 0.84

What is the optimal gestational age for delivery? J Perinatol (2006) 0.84

Randomised trial of outpatient induction of labor with vaginal PGE2 at 40-41 weeks of gestation versus expectant management. Arch Gynecol Obstet (1996) 0.83

Association not causation: what is the intervention? Ann Fam Med (2007) 0.81

Articles by these authors

Selected perinatal outcomes associated with planned home births in the United States. Am J Obstet Gynecol (2013) 3.55

Planned Out-of-Hospital Birth and Birth Outcomes. N Engl J Med (2015) 3.47

Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. N Engl J Med (2007) 3.40

Second stage of labor and epidural use: a larger effect than previously suggested. Obstet Gynecol (2014) 3.38

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol (2012) 2.92

Combination of Foley bulb and vaginal misoprostol compared with vaginal misoprostol alone for cervical ripening and labor induction: a randomized controlled trial. Obstet Gynecol (2013) 2.67

A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol (2004) 2.60

Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol (2010) 2.37

Gestational weight gain and adverse neonatal outcome among term infants. Obstet Gynecol (2006) 2.34

First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31

Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J Matern Fetal Neonatal Med (2013) 2.29

Elective induction of labor at term compared with expectant management: maternal and neonatal outcomes. Obstet Gynecol (2013) 2.27

Progress of labor in women induced with misoprostol versus the Foley catheter. Am J Obstet Gynecol (2013) 2.22

Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women. Am J Obstet Gynecol (2010) 2.22

Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol (2014) 2.22

Interval from loop electrosurgical excision procedure to pregnancy and pregnancy outcomes. Obstet Gynecol (2013) 2.15

Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy? Am J Obstet Gynecol (2007) 2.12

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09

Active management of risk in pregnancy at term in an urban population: an association between a higher induction of labor rate and a lower cesarean delivery rate. Am J Obstet Gynecol (2004) 2.08

Radiographic measures of the mid pelvis to predict cesarean delivery. Am J Obstet Gynecol (2013) 2.08

Terminal fetal heart decelerations and neonatal outcomes. Obstet Gynecol (2013) 2.05

Limited obstetric ultrasound examinations: competency and cost. J Obstet Gynecol Neonatal Nurs (2003) 2.03

Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate). Obstet Gynecol (2011) 2.01

Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis. Obstet Gynecol (2014) 2.00

Perinatal outcomes in low-risk term pregnancies: do they differ by week of gestation? Am J Obstet Gynecol (2008) 1.95

Normal progress of induced labor. Obstet Gynecol (2012) 1.93

Carpenter-Coustan criteria compared with the national diabetes data group thresholds for gestational diabetes mellitus. Obstet Gynecol (2009) 1.92

Risk of stillbirth and infant death stratified by gestational age. Obstet Gynecol (2012) 1.87

The price of emergency contraception in the United States: what is the cost-effectiveness of ulipristal acetate versus single-dose levonorgestrel? Contraception (2012) 1.85

Staples compared with subcuticular suture for skin closure after cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol (2011) 1.81

Vaginal birth after caesarean section versus elective repeat caesarean section: assessment of maternal downstream health outcomes. BJOG (2006) 1.81

Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol (2010) 1.77

Single umbilical artery and its associated findings. Obstet Gynecol (2010) 1.76

How long is too long: Does a prolonged second stage of labor in nulliparous women affect maternal and neonatal outcomes? Am J Obstet Gynecol (2004) 1.67

Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ (2011) 1.67

Cost-effectiveness of private umbilical cord blood banking. Obstet Gynecol (2009) 1.62

Response to letter to the editor. Contraception (2013) 1.62

Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol (2007) 1.61

Congenital uterine anomalies and adverse pregnancy outcomes. Am J Obstet Gynecol (2011) 1.60

Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol (2007) 1.59

Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol (2008) 1.59

Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol (2003) 1.58

Is fetal gender associated with adverse perinatal outcome in intrauterine growth restriction (IUGR)? Am J Obstet Gynecol (2005) 1.56

Forceps delivery volumes in teaching and nonteaching hospitals: are volumes sufficient for physicians to acquire and maintain competence? Acad Med (2014) 1.55

Gestational weight gain, macrosomia, and risk of cesarean birth in nondiabetic nulliparas. Obstet Gynecol (2004) 1.55

Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) (2014) 1.54

Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol (2009) 1.54

Is preeclampsia associated with an increased risk of cesarean delivery if labor is induced? J Matern Fetal Neonatal Med (2010) 1.54

The association between increased use of labor induction and reduced rate of cesarean delivery. J Womens Health (Larchmt) (2009) 1.53

Risk factors for sleep-disordered breathing in pregnancy. Thorax (2013) 1.52

Association of atypical decelerations with acidemia. Obstet Gynecol (2012) 1.50

Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.50

Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses. Am J Obstet Gynecol (2013) 1.49

Maternal and neonatal outcomes of elective induction of labor. Evid Rep Technol Assess (Full Rep) (2009) 1.49

The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol (2009) 1.48

The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol (2010) 1.48

Sleep deprivation during pregnancy and maternal and fetal outcomes: is there a relationship? Sleep Med Rev (2009) 1.47

Is there an upper time limit for the management of the second stage of labor? Am J Obstet Gynecol (2009) 1.47

Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. Obstet Gynecol (2008) 1.46

Predicting adverse neonatal outcomes in fetuses with abdominal wall defects using prenatal risk factors. Am J Obstet Gynecol (2009) 1.46

Safety and efficacy of vaginal birth after cesarean attempts at or beyond 40 weeks of gestation. Obstet Gynecol (2005) 1.45

Use of alcohol-free antimicrobial mouth rinse is associated with decreased incidence of preterm birth in a high-risk population. Am J Obstet Gynecol (2011) 1.44

Utility of the bladder flap at cesarean delivery: a randomized controlled trial. Obstet Gynecol (2012) 1.44

A community-based study of acne-related health preferences in adolescents. Arch Dermatol (2008) 1.44

Does risk of preeclampsia differ by twin chorionicity? J Matern Fetal Neonatal Med (2013) 1.42

Impact of fetal gender on the labor curve. Am J Obstet Gynecol (2012) 1.42

A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem (2001) 1.42

Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol (2008) 1.41

The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia. J Matern Fetal Neonatal Med (2013) 1.41

Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening. Am J Obstet Gynecol (2008) 1.39

Perinatal outcomes among different Asian-American subgroups. Am J Obstet Gynecol (2008) 1.38

Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet (2004) 1.35

Improving diet and exercise in pregnancy with Video Doctor counseling: a randomized trial. Patient Educ Couns (2010) 1.34

Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol (2012) 1.33

Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol (2013) 1.33

Perinatal outcomes among Asian American and Pacific Islander women. Am J Obstet Gynecol (2006) 1.31

Predicting failure of a vaginal birth attempt after cesarean delivery. Obstet Gynecol (2007) 1.30

A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A (2006) 1.27

Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol (2010) 1.26

Gestational weight gain and gestational diabetes mellitus: perinatal outcomes. Obstet Gynecol (2008) 1.23

Weight gain and spontaneous preterm birth: the role of race or ethnicity and previous preterm birth. Obstet Gynecol (2006) 1.22

Short interpregnancy interval: risk of uterine rupture and complications of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 1.21

Is vaginal birth after cesarean (VBAC) or elective repeat cesarean safer in women with a prior vaginal delivery? Am J Obstet Gynecol (2006) 1.19

The interrelationship between ethnicity and obesity on obstetric outcomes. Am J Obstet Gynecol (2005) 1.19

Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization. Fertil Steril (2011) 1.18

Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenat Diagn (2006) 1.18

A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod (2002) 1.17

The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med (2011) 1.17

False-positive 1-hour glucose challenge test and adverse perinatal outcomes. Obstet Gynecol (2004) 1.17

Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. Obstet Gynecol (2008) 1.17

Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol (2013) 1.16

Putting the "M" back in maternal-fetal medicine. Am J Obstet Gynecol (2012) 1.14

Syncytiotrophoblast is a barrier to maternal-fetal transmission of herpes simplex virus. Biol Reprod (2002) 1.14

Periodontal disease and adverse pregnancy outcomes: is there an association? Am J Obstet Gynecol (2009) 1.14

Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci (2013) 1.13

Duration of the second stage of labor in multiparous women: maternal and neonatal outcomes. Am J Obstet Gynecol (2007) 1.13